Cian Healthcare Limited

As of March 31, 2026, Cian Healthcare Limited carries a market capitalization of 171.84M, placing it among publicly traded companies globally. Its enterprise value stands at 446.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Cian Healthcare Limited has 1.72M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Cian Healthcare Limited maintains a current ratio of 0.78, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Cian Healthcare Limited's stock has gained approximately 379.39% over the past 52 weeks. The 50-day moving average sits at 17.44, while the 200-day moving average is 7.82.

As of March 31, 2026, Cian Healthcare Limited holds 11.96M in cash and equivalents against 286.59M in total debt, resulting in a net debt position of 274.62M. Total book value stands at 85.36M, with working capital of -62.74M providing operational flexibility.